Drug therapy of pulmonary arterial hypertension in 2014

Abstract

Pulmonary arterial hypertension (PAH) is a primary pulmonary arteriolar disease, characterized by a progressive increase in pulmonary vascular resistance and pressure in the pulmonary circulation.

Keywords

• Conventional and specific treatment
• Endothelin receptor antagonists
• Experimental treatment options
• Phosphodiesterase 5 inhibitors
• Prostanoids
• Pulmonary arterial hypertension